Literature DB >> 23643489

How to design a drug for the disordered proteins?

Calvin Yu-Chian Chen1, Weng Ieong Tou.   

Abstract

Structural disorders of proteins make drug design a difficult task. The gel-like state of intrinsically disordered protein (IDP) or intrinsically disordered regions (IDRs) remains a big puzzle for drug designers. Here, we propose a novel concept for drug design by understanding protein disintegration and protein-protein interaction (PPI) using molecular dynamics (MD) simulation and propose a possible approach for overcoming current obstacles in IDP drug design.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23643489     DOI: 10.1016/j.drudis.2013.04.008

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  45 in total

1.  Binding cavities and druggability of intrinsically disordered proteins.

Authors:  Yugang Zhang; Huaiqing Cao; Zhirong Liu
Journal:  Protein Sci       Date:  2015-02-24       Impact factor: 6.725

Review 2.  Dynamic conformational flexibility and molecular interactions of intrinsically disordered proteins.

Authors:  Anil Bhattarai; Isaac Arnold Emerson
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

3.  Digested disorder, Quarterly intrinsic disorder digest (October-November-December, 2013).

Authors:  Shelly DeForte; Krishna D Reddy; Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2015-03-09

Review 4.  Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?

Authors:  Tomasz Cierpicki; Jolanta Grembecka
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

5.  Susceptible gene of stasis-stagnation constitution from genome-wide association study related to cardiovascular disturbance and possible regulated traditional Chinese medicine.

Authors:  Kuo-Chin Huang; Hung-Jin Huang; Ching-Chu Chen; Chwen-Tzuei Chang; Tzu-Yuan Wang; Rong-Hsing Chen; Yu-Chian Chen; Fuu-Jen Tsai
Journal:  BMC Complement Altern Med       Date:  2015-07-14       Impact factor: 3.659

6.  An Overview of Practical Applications of Protein Disorder Prediction and Drive for Faster, More Accurate Predictions.

Authors:  Xin Deng; Jordan Gumm; Suman Karki; Jesse Eickholt; Jianlin Cheng
Journal:  Int J Mol Sci       Date:  2015-07-07       Impact factor: 5.923

Review 7.  Identification of inhibitors of biological interactions involving intrinsically disordered proteins.

Authors:  Daniela Marasco; Pasqualina Liana Scognamiglio
Journal:  Int J Mol Sci       Date:  2015-04-02       Impact factor: 5.923

8.  Investigation of the novel lead of melanocortin 1 receptor for pigmentary disorders.

Authors:  Hsin-Chieh Tang; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-17       Impact factor: 2.629

9.  Pharmacological chaperone design for reducing risk factor of Parkinson's disease from traditional chinese medicine.

Authors:  Hung-Jin Huang; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-19       Impact factor: 2.629

10.  Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptor.

Authors:  Kuen-Bao Chen; Hsin-Yi Chen; Kuan-Chung Chen; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.